Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-007884
Filing Date
2019-02-06
Accepted
2019-02-06 19:51:56
Documents
2
Period of Report
2019-02-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 18287
2 POA DOCUMENT poa.txt EX-24.3_830856 2461
  Complete submission text file 0001209191-19-007884.txt   22218
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
GORDON CARL L (Reporting) CIK: 0001282930 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38792 | Film No.: 19573142

Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)